UNMC Leukemia Symposium: Focus on Opportunities to Improve Care

 

UNMC Leukemia Symposium: Focus on Opportunities to Improve Care
G

Novel Treatment Options for AML and Overview of Related Trials - Moving from Standard 7+3 to Combinations and Targeting FLT3, CD33, BCL2 and IDH Inhibitors

By UNMC Leukemia Symposium: Focus on Opportunities to Improve Care FEATURING Gail J. Roboz
By UNMC Leukemia Symposium: Focus on Opportunities to Improve Care FEATURING Gail J. Roboz
383 views
July 19, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Featured Video

37:21
Amgen Sponsorship

New Approval for Frontline Consolidation in Patients with CD19-posit…

Feat. J. Mccloskey
Videos
13:48

Underutilization of Chemotherapy Among Older Adults with AML

UNMC Leukemia Symposium: Focus on Opportunities to Improve Care

V. Bhatt

240 views
13:35

Disparity in the Use of Allo HSCT in AML - Benefit of Allo Transplan…

UNMC Leukemia Symposium: Focus on Opportunities to Improve Care

Z. Al-Kadhimi

104 views
19:40

Late-Effects of Childhood Leukemia Treatment & Guidelines for Long-t…

UNMC Leukemia Symposium: Focus on Opportunities to Improve Care

M. Acquazzino

16 views
22:50

Palliative vs. Hospice Care & Benefits of Early Integration of Palli…

UNMC Leukemia Symposium: Focus on Opportunities to Improve Care

M. Teply

61 views
40:14

Novel Treatment Options for AML and Overview of Related Trials - Mov…

UNMC Leukemia Symposium: Focus on Opportunities to Improve Care

G. Roboz

383 views
24:40

Panel Discussion on Living with Cancer: How to Manage Balancing Work…

UNMC Leukemia Symposium: Focus on Opportunities to Improve Care